Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.79 (
hormone-sensitive lipase
)
2,163
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pseudomonas aeruginosa is an important cause of nosocomial infections and is frequently present in the airways of cystic fibrosis patients. Quorum sensing mediates P. aeruginosa's virulence and biofilm formation through density-dependent interbacterial signaling with autoinducers. N-3-oxododecanoyl homoserine lactone (3OC12-
HSL
) is the major autoinducer in P. aeruginosa. We have previously shown that human airway epithelia and paraoxonases (PONs) degrade 3OC12-
HSL
. This study investigated the role of
PON1
, PON2, and PON3 in airway epithelial cell inactivation of 3OC12-
HSL
. All three PONs were present in murine tracheal epithelial cells, with PON2 and PON3 expressed at the highest levels. Lysates of tracheal epithelial cells from PON2, but not
PON1
or PON3, knockout mice had impaired 3OC12-
HSL
inactivation compared with wild-type mice. In contrast,
PON1
-, PON2-, or PON3-targeted deletions did not affect 3OC12-
HSL
degradation by intact epithelia. Overexpression of PON2 enhanced 3OC12-
HSL
degradation by human airway epithelial cell lysates but not by intact epithelia. Finally, using a quorum-sensing reporter strain of P. aeruginosa, we found that quorum sensing was enhanced in PON2-deficient airway epithelia. In summary, these results show that loss of PON2 impairs 3OC12-
HSL
degradation by airway epithelial cells and suggests that diffusion of 3OC12-
HSL
into the airway cells can be the rate-limiting step for degradation of the molecule.
...
PMID:Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia. 1712 53
The pathogenic bacterium Pseudomonas aeruginosa causes serious infections in immunocompromised patients. N-(3-oxododecanoyl)-L-homoserine lactone (3OC12-
HSL
) is a key component of P. aeruginosa's quorum-sensing system and regulates the expression of many virulence factors. 3OC12-
HSL
was previously shown to be hydrolytically inactivated by the paraoxonase (PON) family of calcium-dependent esterases, consisting of
PON1
, PON2, and PON3. Here we determined the specific activities of purified human PONs for 3OC12-
HSL
hydrolysis, including the common
PON1
polymorphic forms, and found they were in the following order: PON2 >>
PON1
(192R) >
PON1
(192Q) > PON3. PON2 exhibited a high specific activity of 7.6 +/- 0.4 micromols/min/mg at 10 microM 3OC12-
HSL
, making it the best PON2 substrate identified to date. By use of class-specific inhibitors, approximately 85 and 95% of the 3OC12-
HSL
lactonase activity were attributable to
PON1
in mouse and human sera, respectively. In mouse liver homogenates, the activity was metal dependent, with magnesium- and manganese-dependent lactonase activities comprising 10 to 15% of the calcium-dependent activity. In mouse lung homogenates, all of the activity was calcium dependent. The calcium-dependent activities were irreversibly inhibited by extended EDTA treatment, implicating PONs as the major enzymes inactivating 3OC12-
HSL
. In human HepG2 and EA.hy 926 cell lysates, the 3OC12-
HSL
lactonase activity closely paralleled the PON2 protein levels after PON2 knockdown by small interfering RNA treatment of the cells. These findings suggest that PONs, particularly PON2, could be an important mechanism by which 3OC12-
HSL
is inactivated in mammals.
...
PMID:Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone. 1834 34
Pseudomonas aeruginosa uses quorum sensing, an interbacterial communication system, to regulate gene expression. The signaling molecule N-3-oxododecanoyl homoserine lactone (3OC12-
HSL
) is thought to play a central role in quorum sensing. Since 3OC12-
HSL
can be degraded by paraoxonase (PON) family members, we hypothesized that PONs regulate P. aeruginosa virulence in vivo. We chose Drosophila melanogaster as our model organism because it has been shown to be a tractable model for investigating host-pathogen interactions and lacks PONs. By using quorum-sensing-deficient P. aeruginosa, synthetic acyl-HSLs, and transgenic expression of human
PON1
, we investigated the role of 3OC12-
HSL
and
PON1
on P. aeruginosa virulence. We found that P. aeruginosa virulence in flies was dependent upon 3OC12-
HSL
.
PON1
transgenic flies expressed enzymatically active
PON1
and thereby exhibited arylesterase activity and resistance to organophosphate toxicity. Moreover,
PON1
flies were protected from P. aeruginosa lethality, and protection was dependent on the lactonase activity of
PON1
. Our findings show that
PON1
can interfere with quorum sensing in vivo and provide insight into what we believe is a novel role for
PON1
in the innate immune response to quorum-sensing-dependent pathogens. These results raise intriguing possibilities about human-pathogen interactions, including potential roles for
PON1
as a modifier gene and for
PON1
protein as a regulator of normal bacterial florae, a link between infection/inflammation and cardiovascular disease, and a potential therapeutic modality.
...
PMID:Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1. 1870 98
The human paraoxonase 2 (PON2) has been described as a highly specific lactonase hydrolysing the quorum sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone (3OC12-
HSL
) and having secondary esterase but not phosphotriesterase activity, in contrast with the related enzymes
PON1
and PON3. It has been suggested that PON2 enzyme activity is dependent on glycosylation and its N-terminal region has been recently demonstrated to be a transmembrane domain mediating association to membranes. In the present study we describe a mutated form of PON2, lacking the above N-terminal region, which has been further stabilized by the insertion of six amino acidic substitutions. The engineered version, hence forth called rPON2, has been over-expressed in E.coli, refolded from inclusion bodies and purified, yielding an enzyme with the same characteristics as the full length enzyme. Therefore the first conclusion of this work was that the catalytic activity is independent from the N-terminus and protein glycosylation. The kinetic characterization confirmed the primary activity on 3OC12-
HSL
; accordingly, in vitro experiments of inhibition of the biofilm formed by Pseudomonas aeruginosa (PAO1) have demonstrated that rPON2 is more effective than
PON1
. In addition, we observed small but significant activity against organophosphorothiotes pesticides, m-parathion, coumaphos and malathion.The availability of fair amount of active protein allowed to pinpoint, by mass-spectrometry, ubiquitination of Lys 168 induced in rPON2 by HeLa extract and to correlate such post-translational modification to the modulation of catalytic activity. A mutational analysis of the modified residue confirmed the result.
...
PMID:An Engineered Version of Human PON2 Opens the Way to Understand the Role of Its Post-Translational Modifications in Modulating Catalytic Activity. 2665 16